bioRxiv · 10.1101/2025.01.09.632256
scMILD: Single-cell Multiple Instance Learning for Sample Classification and Associated Subpopulation Discovery
Abstract
Linking cellular states to clinical phenotypes is a major challenge in single-cell analysis. Here, we present scMILD, a weakly supervised Multiple Instance Learning framework that robustly identifies condition-associated cells using only sample-level labels. After systematically validating scMILDs accuracy through controlled simulations, we applied it to diverse disease datasets, confirming its ability to retrieve known biological signatures. Building on this, our sample-informed analysis of scMILD-identified monocytes in COVID-19 revealed a temporal transition from an early antiviral to a late stress-response state. Furthermore, in a novel cross-disease application, a model trained on COVID-19 successfully stratified Lupus patients and distinguished shared inflammatory states from disease-specific ones. scMILD thus provides a validated and versatile strategy to dissect cellular heterogeneity, bridging single-cell observations with high-level phenotypes.
Source connections
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Jeong, K., Choi, J., Kim, K.. 2025-01-11. scMILD: Single-cell Multiple Instance Learning for Sample Classification and Associated Subpopulation Discovery. https://doi.org/10.1101/2025.01.09.632256
Cite the original work for its findings. Save a collection to share your selection of sources.